DUBLIN--(BUSINESS WIRE)--The "Global Bacterial Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Bacterial Partnering 2012 to 2018 provides the full collection of Bacterial disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Bacterial disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Bacterial deals.
The report presents financial deal terms values for Bacterial deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Global Bacterial Partnering 2012 to 2018 includes:
- Trends in Bacterial dealmaking in the biopharma industry since 2012
- Analysis of Bacterial deal structure
- Access to headline, upfront, milestone and royalty data
- Access to hundreds of Bacterial deal contract documents
- Comprehensive access to over 3500 Bacterial deal records
- The leading Bacterial deals by value since 2012
Most active Bacterial dealmakers since 2012
Deals and contracts are listed by:
- Headline value
- Upfront payment value
- Royalty rate value
- Stage of development at signing
- Deal component type
- Technology type
Specific therapy indication
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Bacterial dealmaking
Chapter 3 - Financial deal terms for Bacterial partnering
Chapter 4 - Leading Bacterial deals and dealmakers
Chapter 5 - Bacterial contract document directory
Chapter 6 - Bacterial dealmaking by therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/8gr3jh/global_bacterial?w=4